EA
VCYT icon

Evolution Advisers’s Veracyte VCYT Stock Holding History

Evolution Advisers’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
+8
New +$335 ﹤0.01% 869

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Evolution Advisers's VCYT Position: Q2 2026 in Review

Evolution Advisers opened a new position in Veracyte (VCYT) in Q2 2026: 8 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #869 among its holdings.

369 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Evolution Advisers held 8 shares of Veracyte worth $0 as of Q2 2026.
  • Veracyte was a new Evolution Advisers position in Q2 2026.
  • Veracyte made up ﹤0.01% of Evolution Advisers's portfolio in Q2 2026, its #869 holding.
  • 369 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Evolution Advisers's 13F filing for Q2 2026, filed 31 Jul 2026.